Rebecca Jones is vice president of medical services at Imagen Technologies and clinical assistant professor of neuroscience in psychiatry at Weill Cornell Medicine in New York City.
Rebecca Jones
Vice president of medical services
Imagen Technologies
From this contributor
Review: ‘Uncommon Sense’ exquisitely explores autism’s sensory experiences
The play dexterously depicts the struggles — sensory and social — of four characters who occupy distinct places on the autism spectrum.
Review: ‘Uncommon Sense’ exquisitely explores autism’s sensory experiences
By
Rebecca Jones
5 December 2017 | 6 min read
Explore more from The Transmitter
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
By
Carina Heller
20 January 2025 | 7 min read
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
By
Anna Victoria Molofsky
17 January 2025 | 5 min read
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
By
Angie Voyles Askham
16 January 2025 | 6 min read